Roche Pharma India and NIPER Raebareli Join Forces to Revolutionize Pharmaceutical Education
Roche Pharma India and NIPER Raebareli have signed an MoU to boost academic–industry collaboration in the pharmaceutical sector. The partnership aims to close the gap between education and industry, offering students and faculty real-world insights through programs, lectures, and industry exposure. This collaboration supports India's goal of becoming a global biopharmaceutical leader.
- Country:
- India
Roche Pharma India has partnered with the National Institute of Pharmaceutical Education and Research (NIPER) Raebareli to enhance the collaboration between academia and industry in the pharmaceutical field. The partnership, formalized through a Memorandum of Understanding (MoU), was signed in the presence of notable officials at the Department of Pharmaceuticals.
The collaboration aims to bring academic learning closer to real-world industry practices. It includes initiatives like a regulatory affairs certificate program, guest lectures on AI trends in pharmaceuticals, and scholarship-cum-industry exposure opportunities for NIPER students. Through these efforts, participants will gain critical insights into the ever-evolving pharmaceutical and regulatory landscapes.
Speaking on the occasion, Roche Pharma India's CEO emphasized that this partnership will boost India's biopharma sector's global competitiveness. Furthermore, NIPER Raebareli's Director noted the importance of preparing students to face global healthcare challenges. The collaboration marks a significant step towards strengthening India's leadership in biopharmaceutical innovation.